MedKoo Cat#: 463108 | Name: Theobromine-d6
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Theobromine-d6 is intended for use as an internal standard for the quantification of theobromine by GC- or LC-MS. Theobromine is a methylxanthine alkaloid and derivative of caffeine that has been found in cocoa beans and has diverse biological activities. It is an adenosine A1 receptor antagonist. Theobromine increases AMPK phosphorylation and inhibits adipocyte differentiation, ERK and JNK phosphorylation, and IL-6 and TNF-α production in 3T3-L1 preadipocytes cultured in differentiation medium. It inhibits decreases in renal cortex SIRT1 activity and increases in NADPH oxidase-dependent reactive oxygen species (ROS) production, as well as reduces kidney hypertrophy and albuminuria in a spontaneously hypertensive rat model of streptozotocin-induced diabetes when administered at a dose of 5 mg/kg per day.3 Theobromine is toxic to dogs with an LD50 value of 250 to 500 mg/kg.

Chemical Structure

Theobromine-d6
Theobromine-d6
CAS#117490-40-1

Theoretical Analysis

MedKoo Cat#: 463108

Name: Theobromine-d6

CAS#: 117490-40-1

Chemical Formula: C7H2D6N4O2

Exact Mass: 186.1024

Molecular Weight: 186.20

Elemental Analysis: C, 45.15; H, 7.57; N, 30.09; O, 17.18

Price and Availability

Size Price Availability Quantity
1mg USD 550.00 2 Weeks
5mg USD 950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Theobromine-d6;
IUPAC/Chemical Name
3,7-bis(methyl-d3)-3,7-dihydro-1H-purine-2,6-dione
InChi Key
YAPQBXQYLJRXSA-WFGJKAKNSA-N
InChi Code
InChI=1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13)/i1D3,2D3
SMILES Code
O=C(NC1=O)C2=C(N1C([2H])([2H])[2H])N=CN2C([2H])([2H])[2H]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 186.20 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Sherman, M. M., Tarantino, P. M., Morrison, D. N., Lin, C. H., Parente, R. M., & Sippy, B. C. (2022). A double-blind, randomized, two-part, two-period crossover study to evaluate the pharmacokinetics of caffeine versus d9-caffeine in healthy subjects. Regulatory Toxicology and Pharmacology, 133, 105194. Dai, H. R., Guo, H. L., Wang, W. J., Shen, X., Cheng, R., Xu, J., ... & Chen, F. (2024). From “wet” matrices to “dry” blood spot sampling strategy: a versatile LC-MS/MS assay for simultaneous monitoring caffeine and its three primary metabolites in preterm infants. Clinical Chemistry and Laboratory Medicine (CCLM), 62(1), 97-110. Li, L., Paxon, T., Pedada, A., Cen, Y. S., Sherman, M. M., Tarantino, P. M., ... & Wen, H. Methods for the Simultaneous Uplc-Ms/Ms Analysis of Caffeine and its Four Metabolites in Human Plasma or Simultaneous Uplc-Ms/Ms Analysis of Caffeine-D9 and its Four Metabolites in Human Plasma. Ms Analysis of Caffeine and its Four Metabolites in Human Plasma or Simultaneous Uplc-Ms/Ms Analysis of Caffeine-D9 and its Four Metabolites in Human Plasma.